Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Health Services

Dáil Éireann Debate, Tuesday - 13 March 2012

Tuesday, 13 March 2012

Ceisteanna (534, 535)

Michael Healy-Rae

Ceist:

589 Deputy Michael Healy-Rae asked the Minister for Health if he will review a matter (details supplied) regarding an action group; and if he will make a statement on the matter. [13840/12]

Amharc ar fhreagra

Brendan Griffin

Ceist:

591 Deputy Brendan Griffin asked the Minister for Health his views on a matter regarding breast implants (details supplied); the action he will take to address the concerns of the persons involved; and if he will make a statement on the matter. [13879/12]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 589 and 591 together.

The Department is aware of the issues being raised by concerned recipients of PIP implants. Since concerns were first raised regarding the issue of breast implants provided by the now defunct French company Poly Implant Prosthese (PIP) the Irish Medicines Board (IMB) and my Department have been in constant touch with European and UK investigators of the matter and with any relevant initiative involved. Department and the IMB continue to liaise with the Health Security Committee's Health Threats Unit which is maintaining the up to date position on the issue for all Member States. As information on PIP implantation worldwide and within the European Community emerges, my Department and the IMB are continuing to review advice for recipients of PIP implants. The advice remains consistent to date: that there is no evidence of increased risk of cancer for women with this brand of implant, the risk of rupture is low and anyone with a concern about their breast implants should discuss the matter with their GP or surgeon.

My Department is engaged at present in meeting all the treating clinics with a view to ensuring that best practice and patient support is paramount in the service provided to concerned recipients of PIP implants. Chief Medical Officer will arrange to meet the concerned client and colleagues as soon as possible with a view to assisting in the resolution of the concerns raised.

I am satisfied that all relevant emerging information and updates on the PIP implant issue are being thoroughly assessed and all concerned and interested parties kept aware of the emerging position.

Barr
Roinn